VivoPower Confirms Continuation of Proposed US$180 Million Takeover Process: US Tariffs Not Expected to Affect Tembo Business

Stock Information for AnPac Bio-Medical Science Co. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AnPac Bio-Medical Science Co. Ltd.

VivoPower to Originate 450 Million Underlying XRP Tokens Worth an Estimated $900 Million for Lean Ventures Through Targeted Ripple Labs Share Purchase
VivoPower Announces Update to Annual General Meeting
VivoPower Executes $300 Million Definitive Joint Venture Agreement with South Korea-Based Lean Ventures to Acquire and Hold Ripple Labs Shares
VivoPower Enters Heads of Agreement with KOSDAQ Listed KWeather to Launch Initial US$5 Million XRP Focused Digital Asset Reserve & WeatherCoin Tokenization Project in South Korea 
VivoPower's Tembo to Accelerate Africa Expansion in Definitive Agreement with AVA, East Africa's Largest Vehicle Assembler
VivoPower Closes Additional $19 Million Equity Raise Priced at $6.05 Per Share, a Premium to Market
VivoPower Establishes South Korean Office and Appoints Local Representative Director
VivoPower to Procure XRP at up to 65% Discount by Exchanging Mined Tokens from Expanded Digital Asset Mining Fleet

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.